Press Release May 13 2022
Filed with NSE · · 3 pages · English and French
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release announcing the launch of Bemdac, a new drug for treating uncontrolled LDL-Cholesterol in India. This drug is intended for patients who do not achieve desired cholesterol levels despite maximum doses of statins. The launch addresses a significant healthcare need, as many patients struggle with high LDL-Cholesterol levels. Dr. Sharvil Patel emphasized the importance of Bemdac in improving patient quality of life through effective management of dyslipidemia.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release May 06 2022
- Press Release May 03 2022
- Press Release Apr 26 2022
- Press Release Apr 25 2022
- Press Release Apr 18 2022
Later from Zydus Lifesciences
- Press Release May 26 2022
- Press Release May 27 2022
- Press Release Jun 06 2022
- Press Release Jun 07 2022
- Press Release Jun 30 2022
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences